CD14, a pattern recognition receptor on monocyte and macrophage, plays a central role in innate immunity through recognition of bacterial lipopolysaccharide and initiation of inflammatory response. Recently, CD14/À260C4T promoter gene polymorphism has been found to be related to a risk of inflammatory diseases. Our results showed that the C allele frequency among Chinese in Taiwan was lower than those in Western countries. The membrane CD14 expression was significantly higher in TT as compared with CT and CC genotypes (P ¼ 0.034, 0.044, respectively). There was a higher level of soluble CD14 in TT and CT genotypes than in CC genotypes. In addition, TNFa production in whole blood was significantly higher in TT genotype than in CC genotype after stimulation by Chlamydiae. In conclusion, the single base pair polymorphism of CD14 promoter gene is associated with CD14 expression and Chlamydia-stimulated TNFa production, and may thus play some role in the chlamydia-induced inflammatory response.
Introduction
As a pattern recognition receptor on the membrane of monocyte and macrophage, CD14, a membrane glycoprotein, plays a central role in innate immunity through recognition of bacterial lipopolysaccharide (LPS), and initiating an antimicrobial response. 1 Membrane CD14 (mCD14) is a 54-kDa glycoprotein that was initially known as a myeloid differentiation marker. Soluble CD14 (sCD14) is released in two isoforms (49 and 55 kDa) from monocytes, both are lacking the glycosylphosphatidylinositol (GPI) anchoring. 2, 3 At the molecular level, CD14 acts by transferring LPS and other bacterial ligands from circulating LPS-binding protein to Toll-like receptor 4/MD-2 signaling complex. 4 Engagement of this complex resulted in activation of innate host defense mechanisms such as the release of inflammatory cytokines, and in upregulation of co-stimulatory molecules, thus providing cues that are essential to directing adaptive immune response. 5, 6 A À260C4T (also known as À159C4T) polymorphism in the CD14 gene promoter results in decreased affinity of DNA/protein interaction at a GC box that contains a binding site for Sp proteins and modulates the activity of the promoter. 7 Two groups have studied the promoter gene polymorphism in patients with myocardial infarction, and found that individuals homozygous for the T nucleotide had an increased risk for myocardial infarction. 8, 9 Thus, the two allelic variants of CD14 promoter may be important for infectious and inflammatory diseases, and this CD14 polymorphism could be a genetic factor responsible for interindividual differences in the susceptibility to infection. In our previous study, a significant association of TT genotype and Chlamydia pneumoniae (C pneumoniae) infection was found. 10 Chlamydiae are obligate intracellular Gram negative bacteria. Infection with Chlamydiae is usually followed by a chronic inflammatory response that releases various cytokines. Recently, there has been increasing evidence that chronic or recurrent chlamydial infection of vessel walls might contribute to atherogenesis and possibly to plaque destabilization, as well as to acute coronary syndromes. 11 Several investigators have reported that whole chlamydial elementary bodies (EB) and LPS preparations are capable of stimulating mononuclear phagocytes. 5, 12 In addition, macrophage activation and subsequent release of tumor necrosis factor alpha (TNFa), a pleiotropic cytokine, has been reported as an important part of the cell-mediated and nonspecific immune response following chlamydial infection. 13 Variation in the production of TNFa after various stimuli in healthy subjects might explain predispositions to the development of certain complications or phenotypes of infectious and immuno-inflammatory diseases. It was also reported that differences in the capacity for TNFa production might be related to genetic background. 14 This study is aimed at investigating the relationship between the expression of monocyte mCD14 and plasma levels of sCD14, and the CD14 genotype in healthy subjects; to assess the intersubject variations in TNFa production after LPS and Chlamydial stimulation in whole blood cell culture, and to evaluate whether individuals of variant CD14/À260 gene polymorphism are significantly different in basal level and induced variability of TNF-a production upon LPS stimulation and chlamydial infection.
Results and discussion
CD14/À260 genotypes were identified for 165 healthy subjects (age 19-45 years; mean7s.d., 26.875.3 years; 84 females and 81 males). The frequencies of TT, CT, and CC were 24.2, 55.8, and 20.0% respectively. The T allele was 52.7% and C allele was 47.9%. Allele frequency and genotype distribution was very similar to the expected Hardy-Weinberg equilibrium. The distribution of CC genotype in Taiwan is significantly low as compared with those in Western countries. 9, 15, 16 The mean fluorescence intensity (MFI) of mCD14 on PBMC and plasma levels of sCD14 were measured in 84 healthy individuals (age 20-45 years; mean7s.d., 23.874.3 years; 44 females and 40 males). As shown in Figure 1 , mCD14 in TT genotypes (mean: 1818) are significantly higher than those in CT (mean: 1517; P ¼ 0.044) and CC (mean: 1603; P ¼ 0.034) genotypes. The plasma levels of sCD14 in CC (mean: 466 ng/ml) genotype are lower than TT (mean: 622 ng/ml; P ¼ 0.105) and CT (mean: 644 ng/ml; P ¼ 0.046) genotypes. Subjects with T allele at À260 site have significantly higher sCD14 levels than subjects with non-T allele (635 vs 466 ng/ml; P ¼ 0.035). In contrast, the mCD14 of subjects with non-C allele was significantly higher than C allele (1818 vs 1507; P ¼ 0.021). Our findings confirm that CD14 protein expression is under genetic control. Our data are consistent with previous reports, where Hubacek et al 8 demonstrated an increased expression of CD14 on the surface of monocytes in carriers of the TT genotype, Baldini et al 17 also found the polymorphism to associate with circulating sCD14 levels. However, these findings are in contrast with the results obtained by two other groups, who did not find an association between CD14 expression and CD14 promoter gene polymorphism. 18, 19 Ito et al 18 found no association of CD14 promoter gene polymorphism with either the concentration of sCD14 or the density of mCD14 on monocytes in patients with cerebrovascular disease (CVD). It could be speculated that the monocytes were activated in CVD, but the sample size was small (n ¼ 30) for mCD14 determination. Heesen et al 19 analyzed 95 healthy blood donors and found no statistically significant difference between the mCD14 density of individuals with various genotypes. A possible explanation for the different finding between our study and that of Heesen et al 19 is that the polymorphism at site À260 per se may not be responsible for altering CD14 expression. It may be in the linkage dysequilibrium with another mutation that influences CD14 expression in different ethic groups.
To further investigate the influence of the polymorphism on proinflammatory cytokines induction, we analyzed TNFa production in two CD14 (À260) genotypes (12 CC and 14 TT), randomly selected from healthy subjects after genotyping, by ex vivo LPS and Chlamydia stimulations of whole blood. In both CC and TT groups, LPS induced TNFa production in a dose-dependent manner (Figure 2) . Particularly, after 24 h incubation, the mean TNFa production by 100 ng/ml LPS stimulation CD14 polymorphism and TNFa production HL Eng et al was higher in TT genotype than in CC genotype (2086.6 vs 1691.2 pg/ml). However, it is not statistically significant (P ¼ 0.363). The mean amounts of TNFa production in a 24-h whole blood cell culture after being stimulated with C pneumoniae (TW183) and C trachomatis (UW5) were also in a dose-dependent manner ( Figure 3) . The mean production of TNFa in the TT group is significantly higher than in the CC group, when they were stimulated by C. pneumoniae, TW183 with doses of 1 Â 10 7 IFU (3683.5 vs 5526.0 pg/ml, P ¼ 0.014) (Figure 3a) . Similar results were observed when they were stimulated by C. trachomatis, UW-5 with doses of 2 Â 10 6 and 1 Â 10 7 IFU (P ¼ 0.041 and 0.017, respectively) ( Figure 3b) .
Genetically determined increased expression of CD14 could be associated with a high response to LPS. Temp et al 20 reported a higher TNFa mRNA level in the TT subjects than in the CC after incubation with LPS or Escherichia coli. In our present study, after LPS stimulation the TT also had higher TNFa production than the CC genotypes, but the difference was not statistically significant. However, a statistically significant difference was observed only by chlamydial infection either by C pneumoniae or C trachomatis. Although chlamydial LPS had been reported to be less potent than E coli LPS in eliciting TNFa production, 21 Chlamydiae might still have components other than LPS to stimulate monocytes mediated CD14 to produce TNFa. The outer surface of Chlamydiae contains two major antigens, LPS and the major outer membrane protein (MOMP). During the course of natural and experimental infection, both antigens interact with the immune system to induce antibodies directed against MOMP 22 and LPS 23 in the sera of infected patients. Recently, a second protein has , and 2 Â 10 7 IFU) of (a) C pneumoniae (TW183) and (b) C trachomatis (UW-5) for 24 h at 371C. TNF-a was determined in cell-free supernatants after 24 h of incubation by ELISA. Data are depicted as a box and whiskers blot that gives the range of values, with the box being subdivided into the 25 and 75% quantiles by the median; 50% of all values that lie within the box. Data are means7s.e. represented as the mean with 25th and 75th percentiles of the 12 volunteers in the CC group and 14 volunteer in the TT group. The stimulated TNFa production was statistically analyzed by Mann-Whitney test. *Po0.05 when compared with the CC and TT groups.
been associated with pathogenic chlamydia, it is the heat shock protein, Hsp-60, which produces inflammatory changes in experimental models of trachoma. 24 Netea et al 25 demonstrated that chlamydial endotoxin and acellular components of C pneumoniae are potent stimulus for cytokine production, and this mechanism may have an important role in the inflammatory aspects of atherogenesis. LPS and Hsp-60 are both biologically active in vitro and can induce secretion of inflammatory cytokines, and they are implicated in the pathogenesis of other chronic inflammatory chlamydial diseases (ie, trachoma, pelvic inflammatory disease). 26 Hsp-60 was reported to activate human PBMC and monocytederivated macrophages through CD14 signaling and p38 mitogen-activated protein kinase, and sharing this pathway with LPS. 27 However, the role of these protein antigens, MOMP and Hsp-60, relative to LPS, in the inflammatory response to infection has not been well characterized. With the infection of C pneumoniae and with the increased production of their TNFa, it may lead to chronic inflammatory reaction. Therefore, the TT subjects may have an increased inflammatory reaction to chlamydial infection, a process that may promote atherogenesis and plaque rupture.
In conclusion, the single base pair polymorphism of CD14 promoter gene is associated with CD14 expression and Chlamydia-stimulated TNFa production, and may thus play some role in the chlamydia-induced inflammatory response. In addition, Toll-like receptors (TLR) have been shown to be important components of CD14 signaling complex and TLR2 and TLR4 have both been shown to contribute to the LPS and Hsp-60 responses of chlamydial infection. 28 Further study on the roles of TLR2 and TLR4 gene polymorphisms contributes to the TNFa production of LPS stimulation and chlamydial infection is necessary.
